What's happening
This bill creates new registration, licensing, transparency, and accountability requirements for pharmacy benefit managers operating in New York State.
Why it matters
Shifts PBM fiduciary responsibility toward patients. The bill creates a legal duty for pharmacy benefit managers (PBMs) to act in the best interest of patients (covered individuals) and health plans/providers, requiring care, skill, and prioritization of the patient’s interest in case of conflicts—potentially improving patient outcomes and transparency.
Limits PBM profit strategies and mandates transparency. It restricts "spread pricing" (PBMs keeping the difference between what they charge health plans and pay pharmacies) and requires annual accounting/disclosure of rebates, discounts, and other financial arrangements, aiming to prevent hidden profits and ensure savings benefit health plans and patients.
Empowers pharmacies and consumers. The bill protects pharmacies and consumers by prohibiting PBMs from penalizing pharmacists for disclosing drug prices or alternative purchasing methods, and sets up a standardized, enforceable appeals process for pharmacies to challenge PBM reimbursement rates on generic drugs—potentially leading to fairer pharmacy payments and more informed consumers.
Establishes rigorous state oversight and enforcement. By requiring PBMs to register and obtain licenses, submit to regular reporting and audits, and face significant penalties for violations—including suspension or revocation of licenses—the bill gives state regulators new tools to monitor and discipline PBMs, aiming to reduce anti-competitive, deceptive, or unfair practices in the prescription drug market.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Regulate Pharmacy Benefit Managers
Plain English, a few words. Used as the page title.
Sponsors
40 Co-sponsors
- Kevin Cahill
- Taylor Darling
- Jeffrey Dinowitz
- Harvey Epstein
- Judy Griffin
- Steve Stern
- Chris Tague
- Al Taylor
- Fred Thiele
- Kenneth Zebrowski
- David Weprin
- Linda Rosenthal
- Steven Cymbrowitz
- Pamela J. Hunter
- Aileen Gunther
- Sandy Galef
- David McDonough
- Edward Ra
- Marjorie Byrnes
- Rebecca Seawright
- Steven Englebright
- Billy Jones
- Jo Anne Simon
- Didi Barrett
- Kimberly Jean-Pierre
- Michael J. Norris
- Steven Otis
- Donna Lupardo
- Angelo J. Morinello
- Marianne Buttenschon
- Monica P. Wallace
- Harry B. Bronson
- Phil Steck
- Michael Montesano
- Thomas Abinanti
- William Colton
- Chris Burdick
- Andrew Hevesi
- John T. McDonald III
- Amy Paulin
History
- Substituted by S3762
- Rules report cal.531
- Reported
- Reported referred to rules
- Reported referred to ways and means
- Reported referred to codes
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Regulate Pharmacy Benefit Managers
Signed by Governor · Sponsor Neil D. Breslin
Full text
12 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1396
2021-2022 Regular Sessions
IN ASSEMBLY
January 11, 2021
Introduced by M. of A. GOTTFRIED, CAHILL, DARLING, DINOWITZ, EPSTEIN, GRIFFIN, STERN, TAGUE, TAYLOR, THIELE, ZEBROWSKI, WEPRIN, L. ROSEN- THAL, CYMBROWITZ, HUNTER, GUNTHER, GALEF, McDONOUGH, RA, BYRNES, SEAWRIGHT, ENGLEBRIGHT, JONES, SIMON, BARRETT, JEAN-PIERRE, NORRIS, OTIS, LUPARDO, MORINELLO, BUTTENSCHON, WALLACE -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; and to repeal certain provisions of the public health law relating thereto
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 280-a of the public health law is REPEALED and a new section 280-a is added to read as follows:
§ 280-a. Pharmacy benefit managers. 1. Definitions. As used in this section, the following terms shall have the following meanings:
(a) "Health plan or provider" means an entity for which a pharmacy benefit manager provides pharmacy benefit management including, but not limited to: (i) a health benefit plan or other entity that approves, provides, arranges for, or pays for health care items or services, under which prescription drugs for beneficiaries of the entity are purchased or which provides or arranges reimbursement in whole or in part for the purchase of prescription drugs; or (ii) a health care provider or professional that acquires prescription drugs to use or dispense in providing health care to patients where the prescription drug is the subject of the pharmacy benefit manager's pharmacy benefit management services.
(b) "Pharmacy benefit management services" means the service provided to a health plan or provider, directly or through another entity, and regardless of whether the pharmacy benefit manager and the health plan or provider are related, or associated by ownership, common ownership,
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00570-01-1
A. 1396 2
organization or otherwise; including the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits, including but not limited to, any of the following:
(i) mail service pharmacy;
(ii) claims processing, retail network management, or payment of claims to pharmacies for dispensing prescription drugs;
(iii) clinical or other formulary or preferred drug list development or management;
(iv) negotiation or administration of rebates, discounts, payment differentials, or other incentives, for the inclusion of particular prescription drugs in a particular category or to promote the purchase of particular prescription drugs;
(v) patient compliance, therapeutic intervention, or generic substitution programs;
(vi) disease management;
(vii) drug utilization review or prior authorization;
(viii) adjudication of appeals or grievances related to prescription drug coverage;
(ix) contracting with network pharmacies; and
(x) controlling the cost of covered prescription drugs.
(c) "Pharmacy benefit manager" means any entity that performs pharmacy benefit management services for a health plan or provider.
(d) "Maximum allowable cost price" means a maximum reimbursement amount set by the pharmacy benefit manager for therapeutically equivalent multiple source generic drugs.
(e) "Controlling person" means any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.
(f) "Covered individual" means a member, participant, enrollee, contract holder or policy holder or beneficiary of a health plan or provider.
(g) "License" means a license to be a pharmacy benefit manager, under article twenty-nine of the insurance law.
(h) "Spread pricing" means the practice of a pharmacy benefit manager retaining an additional amount of money in addition to the amount paid to the pharmacy to fill a prescription.
(i) "Superintendent" means the superintendent of financial services.
2. Duty, accountability and transparency. (a) The pharmacy benefit manager shall have a duty and obligation to the covered individual and the health plan or provider, and shall perform pharmacy benefit management services with care, skill, prudence, diligence, and professionalism, and for the best interests of the covered individual, and the health plan or provider. Where there is a conflict in the pharmacy benefit manager's duty or obligation under this paragraph to the covered individual and any other party, the duty or obligation to the covered individual shall be primary.
(b) All funds received by the pharmacy benefit manager in relation to providing pharmacy benefit management services shall be received by the pharmacy benefit manager in trust for the health plan or provider and shall be used or distributed only pursuant to the pharmacy benefit manager's contract with the health plan or provider or applicable law; including any administrative fee or payment to the pharmacy benefit manager expressly provided for in the contract to compensate the pharmacy benefit manager for its services. Any funds received by the pharmacy
A. 1396 3
benefit manager through spread pricing shall be subject to this paragraph.
(c) The pharmacy benefit manager shall account, annually or more frequently to the health plan or provider for any pricing discounts, rebates of any kind, inflationary payments, credits, clawbacks, fees, grants, chargebacks, reimbursements, or other benefits received by the pharmacy benefit manager. The pharmacy benefit manager shall ensure that any portion of such income, payments, and financial benefits is passed through to the health plan or provider in full to reduce the reportable ingredient cost. The health plan or provider shall have access to all financial and utilization information of the pharmacy benefit manager in relation to pharmacy benefit management services provided to the health plan or provider.
(d) The pharmacy benefit manager shall disclose in writing to the health plan or provider the terms and conditions of any contract or arrangement between the pharmacy benefit manager and any party relating to pharmacy benefit management services provided to the health plan or provider including but not limited to, dispensing fees paid to the pharmacies.
(e) The pharmacy benefit manager shall disclose in writing to the health plan or provider any activity, policy, practice, contract or arrangement of the pharmacy benefit manager that directly or indirectly presents any conflict of interest with the pharmacy benefit manager's relationship with or obligation to the health plan or provider.
(f) Any information required to be disclosed by a pharmacy benefit manager to a health plan or provider under this section that is reasonably designated by the pharmacy benefit manager as proprietary or trade secret information shall be kept confidential by the health plan or provider, except as required or permitted by law, including disclosure necessary to prosecute or defend any legitimate legal claim or cause of action.
(g) The superintendent, in consultation with the commissioner:
(i) may make regulations defining, limiting, and relating to the duties, obligations, requirements and other provisions relating to pharmacy benefit managers under this subdivision; and
(ii) shall establish, by regulation, minimum standards for pharmacy benefit management services which shall address the elimination of: conflicts of interest between pharmacy benefit managers and covered individuals, health benefit plans and health care providers; spread pricing; and deceptive practices, anti-competitive practices, and unfair claims practices.
(h) A health care provider and a covered individual shall be deemed to be third-party beneficiaries of the duties, obligations and requirements applicable to the pharmacy benefit manager under this section and shall be entitled to legal or equitable relief for any injury or loss to the health care provider or the covered individual caused by any violation of such duties, obligations or requirements.
3. Prescriptions. A pharmacy benefit manager may not substitute or cause the substituting of one prescription drug for another in dispensing a prescription, or alter or cause the altering of the terms of a prescription, except with the approval of the prescriber or as explicitly required or permitted by law.
4. Appeals. A pharmacy benefit manager shall, with respect to contracts between a pharmacy benefit manager and a pharmacy or, alternatively, a pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization, include a
A. 1396 4
reasonable process to appeal, investigate and resolve disputes regarding multi-source generic drug pricing. The appeals process shall include the following provisions:
(a) the right to appeal by the pharmacy and/or the pharmacy's contracting agent shall be limited to thirty days following the initial claim submitted for payment;
(b) a telephone number through which a network pharmacy may contact the pharmacy benefit manager for the purpose of filing an appeal and an electronic mail address of the individual who is responsible for processing appeals;
(c) the pharmacy benefit manager shall send an electronic mail message acknowledging receipt of the appeal. The pharmacy benefit manager shall respond in an electronic message to the pharmacy and/or the pharmacy's contracting agent filing the appeal within seven business days indicating its determination. If the appeal is determined to be valid, the maximum allowable cost for the drug shall be adjusted for the appealing pharmacy effective as of the date of the original claim for payment. The pharmacy benefit manager shall require the appealing pharmacy to reverse and rebill the claim in question in order to obtain the corrected reimbursement;
(d) if an update to the maximum allowable cost is warranted, the pharmacy benefit manager or covered entity shall adjust the maximum allowable cost of the drug effective for all similarly situated pharmacies in its network in the state on the date the appeal was determined to be valid; and
(e) if an appeal is denied, the pharmacy benefit manager shall identify the national drug code of a therapeutically equivalent drug, as determined by the federal Food and Drug Administration, that is available for purchase by pharmacies in this state from wholesalers registered pursuant to subdivision four of section sixty-eight hundred eight of the education law at a price which is equal to or less than the maximum allowable cost for that drug as determined by the pharmacy benefit manager.
5. Contract provisions. No pharmacy benefit manager shall, with respect to contracts between such pharmacy benefit manager and a pharmacy or, alternatively, such pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization:
(a) prohibit or penalize a pharmacist or pharmacy from disclosing to an individual purchasing a prescription medication information regarding:
(i) the cost of the prescription medication to the individual, or
(ii) the availability of any therapeutically equivalent alternative medications or alternative methods of purchasing the prescription medication, including but not limited to, paying a cash price;
(b) charge or collect from an individual a copayment that exceeds the total submitted charges by the pharmacy for which the pharmacy is paid. If an individual pays a copayment, the pharmacy shall retain the adjudicated costs and the pharmacy benefit manager shall not redact or recoup the adjudicated cost; or
(c) require a pharmacy to meet any pharmacy accreditation standard or recertification requirement inconsistent with, more stringent than, or in addition to federal and state requirements for licensure as a pharmacy.
§ 2. The insurance law is amended by adding a new article 29 to read as follows:
A. 1396 5
ARTICLE 29
PHARMACY BENEFIT MANAGERS Section 2901. Definitions.
2902. Acting without a registration.
2903. Registration requirements for pharmacy benefit managers.
2904. Reporting requirements for pharmacy benefit managers.
2905. Acting without a license.
2906. Licensing of a pharmacy benefit manager.
2907. Revocation or suspension of a registration or license of a
pharmacy benefit manager.
2908. Penalties for violations.
2909. Stay or suspension of superintendent's determination.
2910. Revoked registrations or licenses.
2911. Change of address.
2912. Applicability of other laws.
2913. Assessments.
§ 2901. Definitions. For purposes of this article:
(a) "Controlling person" is any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.
(b) The terms "covered individual", "health plan or provider", "pharmacy benefit manager" and "pharmacy benefit management services" have the same meanings as defined by section two hundred eighty-a of the public health law.
§ 2902. Acting without a registration. (a) No person, firm, association, corporation or other entity may act as a pharmacy benefit manager on or after April first, two thousand twenty-one and prior to January first, two thousand twenty-three, without having a valid registration as a pharmacy benefit manager filed with the superintendent in accordance with this article and any regulations promulgated thereunder.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.